Minerva Neurosciences (NERV) AGM 2026 summary

Opening remarks and agenda

• CEO welcomed attendees, introduced board members, management, and independent auditors, and outlined meeting conduct and access to proxy materials.

• Polls were opened for voting on all matters, and attendees were informed about the process for submitting questions.

Board and executive committee updates

• Two Class III directors, Dr. David Kupfer and Jan van Heek, were elected to serve until the 2029 annual meeting.

Shareholder proposals

• Six proposals were presented: election of directors, amendments to the certificate of incorporation (exculpation of officers and elimination of exclusive forum), advisory votes on executive compensation and its frequency, and ratification of the independent auditor.